SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001069530-21-000022
Filing Date
2021-03-31
Accepted
2021-03-31 16:25:06
Documents
4
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A sava-20201231xdef14a.htm DEF 14A 1018936
2 GRAPHIC sava-20201231xdef14ag001.jpg GRAPHIC 3888
3 GRAPHIC sava-20201231xdef14ag002.jpg GRAPHIC 145696
4 GRAPHIC sava-20201231xdef14ag003.jpg GRAPHIC 171897
  Complete submission text file 0001069530-21-000022.txt   1463282
Mailing Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731
Business Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-29959 | Film No.: 21793690
SIC: 2834 Pharmaceutical Preparations